Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2013³â 16±Ç 1È£ p.22 ~ 27
¹ÚÁö¼÷, ¼­ÁöÇö, À±Èñ»ó,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁö¼÷ ( Park Ji-Sook ) 
Gyeongsang National University School of Medicine Department of Pediatrics

¼­ÁöÇö ( Seo Ji-Hyun ) 
Gyeongsang National University School of Medicine Department of Pediatrics
À±Èñ»ó ( Youn Hee-Shang ) 
Gyeongsang National University School of Medicine Department of Pediatrics

Abstract


The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.

Å°¿öµå

Obesity;Microbiota;Non-alcoholic fatty liver disease

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS